BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 15578276)

  • 21. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
    Cuajungco MP; Fagét KY
    Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
    Rana M; Sharma AK
    Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two macrocyclic polyamines as modulators of metal-mediated Aβ40 aggregation.
    Yang Y; Chen T; Zhu S; Gu X; Jia X; Lu Y; Zhu L
    Integr Biol (Camb); 2015 Jun; 7(6):655-62. PubMed ID: 25968625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutics for Alzheimer's disease based on the metal hypothesis.
    Bush AI; Tanzi RE
    Neurotherapeutics; 2008 Jul; 5(3):421-32. PubMed ID: 18625454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
    Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
    Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.
    Abelein A
    Acc Chem Res; 2023 Oct; 56(19):2653-2663. PubMed ID: 37733746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.
    Robinson SR; Bishop GM
    Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
    Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
    Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.
    Cheng XR; Hau BY; Veloso AJ; Martic S; Kraatz HB; Kerman K
    Anal Chem; 2013 Feb; 85(4):2049-55. PubMed ID: 23276205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual histology of Alzheimer's disease: Biometal entrapment within amyloid-β plaques allows for detection via X-ray phase-contrast imaging.
    Chourrout M; Sandt C; Weitkamp T; Dučić T; Meyronet D; Baron T; Klohs J; Rama N; Boutin H; Singh S; Olivier C; Wiart M; Brun E; Bohic S; Chauveau F
    Acta Biomater; 2023 Oct; 170():260-272. PubMed ID: 37574159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.
    Cerpa W; Dinamarca MC; Inestrosa NC
    Curr Alzheimer Res; 2008 Jun; 5(3):233-43. PubMed ID: 18537540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes.
    Nardo L; Re F; Brioschi S; Cazzaniga E; Orlando A; Minniti S; Lamperti M; Gregori M; Cassina V; Brogioli D; Salerno D; Mantegazza F
    Biochim Biophys Acta; 2016 Apr; 1860(4):746-56. PubMed ID: 26774643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
    Caragounis A; Du T; Filiz G; Laughton KM; Volitakis I; Sharples RA; Cherny RA; Masters CL; Drew SC; Hill AF; Li QX; Crouch PJ; Barnham KJ; White AR
    Biochem J; 2007 Nov; 407(3):435-50. PubMed ID: 17680773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of metals as therapeutic targets in Alzheimer's disease.
    Finefrock AE; Bush AI; Doraiswamy PM
    J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
    Cherny RA; Legg JT; McLean CA; Fairlie DP; Huang X; Atwood CS; Beyreuther K; Tanzi RE; Masters CL; Bush AI
    J Biol Chem; 1999 Aug; 274(33):23223-8. PubMed ID: 10438495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Rapid Exchange of Zinc(2+) Enables Trace Levels to Profoundly Influence Amyloid-β Misfolding and Dominates Assembly Outcomes in Cu(2+)/Zn(2+) Mixtures.
    Matheou CJ; Younan ND; Viles JH
    J Mol Biol; 2016 Jul; 428(14):2832-46. PubMed ID: 27320389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
    Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
    Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aβ
    Anand BG; Prajapati KP; Kar K
    Biochem Biophys Res Commun; 2018 Jun; 501(1):158-164. PubMed ID: 29723530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.